Driving CAR T cell translation forward.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30814337.
- Also identified by DOI 10.1126/scitranslmed.aaw2127.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Successes in CAR T cell translation have propelled their commercial launch, but expanding the impact of cancer immunotherapies remains challenging.
Medical subject headings
- Immunotherapy, Adoptive
- Translational Research, Biomedical